Palmisano Robert J - Aug 31, 2024 Form 4/A - Amendment Insider Report for AEON Biopharma, Inc. (AEON)

Role
Director
Signature
/s/ Alexander Wilson as attorney-in-fact for Robert J. Palmisano
Stock symbol
AEON
Transactions as of
Aug 31, 2024
Transactions value $
$0
Form type
4/A - Amendment
Date filed
9/10/2024, 09:04 PM
Date Of Original Report
Sep 4, 2024
Previous filing
Jun 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AEON Class A Common Stock Award $0 +36K $0.00 36K Aug 31, 2024 Direct F1
holding AEON Class A Common Stock 2.27M Aug 31, 2024 By Family LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
F2 Represents shares of Class A Common Stock which are held by The Palmisano Family, LLC pursuant to recent pro rata distributions on July 19, 2024 as to 1,115,000 shares and on July 25, 2024 as to 1,150,000 shares, and which were inadvertently omitted from the reporting person's Form 4 filed on 9/4/2024.